Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-01-25

FDA Approved: TAMOXIFEN CITRATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Tamoxifen Citrate submitted by Actavis Pharma, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tamoxifen citrate (tamoxifen citrate)

Snippet

SUPPL AP for TAMOXIFEN CITRATE (TAMOXIFEN CITRATE)